v3.26.1
Critical accounting estimates and judgements (Tables)
12 Months Ended
Dec. 31, 2025
Critical Accounting Estimates And Judgements  
Schedule of fair value of the asset
               
   % change in fair value 
   2025   2024   2023 
MTX228 tolimidone acquired IPRD*   40%   41%   18%
MTX230 eRapa acquired IPRD*   20%   19%   n/a